Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Method to Isolate Inflammatory Cells From Skin Biopsies of Patients With Various Pathologies for Quantitative Flow Cytometry Analysis

NCT02270411 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT02270411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02270411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Method to Isolate Inflammatory Cells From Skin Biopsies of Patients With Various Pathologies for Quantitative Flow Cytometry Analysis
Lead sponsor
Innovaderm Research Inc.
Phase
Observational
Overall status
Completed
Start date
May 31, 2014
Completion date
December 31, 2023
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne rosacea, acne vulgaris, atopic dermatitis